Summary
A series of non-peptide angiotensin II receptor antagonists was investigated with the aim of developing a 3D QSAR model using comparative molecular field analysis descriptors and approaches. The main goals of the study were dictated by an interest in methodologies and an understanding of the binding requirements to the AT1 receptor. Consistency with the previously derived activity models was always checked to contemporarily test the validity of the various hypotheses. The specific conformations chosen for the study, the procedures invoked to superimpose all structures, the conditions employed to generate steric and electrostatic field values and the various PCA/PLS runs are discussed in detail. The effect of experimental design techniques to select objects (molecules) and variables (descriptors) with respect to the predictive power of the QSAR models derived was especially analysed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Reid, J.L. and Rubin, P.C., Physiol. Rev., 67 (1987) 725.
Valloton, M.B., Trends Pharmacol. Sci., 8 (1987) 69.
Greenlee, W.J. and Mantlo, N.B. (Eds.) Recent Advances in the Design and Synthesis of Angiotensin II Receptor Antagonists, Bioorg. Med. Chem. Lett., 4 (1994), Symposia-in-Print 9.
Belvisi, L., Bravi, G., Scolastico, C., Vulpetti, A., Salimbeni, A. and Todeschini, R., J. Comput.-Aided Mol. Design, 8 (1994) 211.
Carini, D.J., Duncia, J.V., Aldrich, P.E., Chiu, A.T., Johnson, A.L., Pierce, M.E., Price, W.A., SantellaIII, J.B., Wells, G.J., Wexler, R.R., Wong, P.C., Yoo, S.E. and Timmermans, P.B.M.W.M., J. Med. Chem., 34 (1991) 2525.
Prendergast, K., Adams, K., Greenlee, W.J., Nachbar, R.B., Patchett, A.A. and Underwood, D.J., J. Comput.-Aided Mol. Design. 8 (1994) 491.
Belvisi, L., Bonati, L., Bravi, G., Pitea, D., Scolastico, C. and Vulpetti, A., J. Mol. Struct. (THEOCHEM), 281 (1993) 237.
Salimbeni, A., Canevotti, R., Paleari, F., Bonaccorsi, F., Renzetti, A.R., Belvisi, L., Bravi, G. and Scolastico, C., J. Med. Chem. 37 (1994) 3928.
CramerIII, R.D., Patterson, D.E. and Bunce, J.D., J. Am. Chem. Soc., 110 (1988) 5959.
Kubinyi, H. (Ed.) 3D QSAR in Drug Design: Theory, Methods and Applications, ESCOM, Leiden, The Netherlands, 1993.
Cruciani, G., Clementi, S. and Baroni, M., In Kubinyi, H. (Ed.) 3D QSAR in Drug Design: Theory, Methods and Applications, ESCOM, Leiden, The Netherlands, 1993, pp. 551–564.
Clementi, S., Cruciani, G., Baroni, M. and Costantino, G., In Kubinyi, H. (Ed.) 3D QSAR in Drug Design: Theory, Methods and Applications, ESCOM, Leiden, The Netherlands, 1993, pp. 567–582.
Carini, D.J., Duncia, J.V., Johnson, A.L., Chiu, A.T., Price, W.A., Wong, P.C. and Timmermans, P.B.M.W.M., J. Med. Chem., 33 (1990) 1330.
Carini, D.J. and Duncia, J.V., Eur. Pat. 253 310, 1988 (Chem. Abstr. 109, 129008g, 1988).
Carini, D.J., Wells, G.J. and Duncia, J.V., Eur. Pat. 323 841, 1989 (Chem. Abstr. 112, 55881z, 1990).
Unpublished results of LusoFarmaco Laboratories, related to A. Menarini — Industrie Farmaceutiche Riunite.
Thomas, A.P., Allott, C.P., Gibson, K.H., Major, J.S., Masek, B.B., Oldham, A.A., Ratcliffe, A.H., Roberts, D.A., Russell, S.T. and Thomason, D.A., J. Med. Chem., 35 (1992) 877.
Bradbury, R.H., Allott, C.R., Dennis, M., Fisher, E., Major, J.S., Masek, B.B., Oldham, A.A., Pearce, R.J., Rankine, N., Revill, J.M., Roberts, D.A. and Russell, S.T., J. Med. Chem., 35 (1992) 4027.
Bradbury, R.H., Allott, C.P., Dennis, M., Girwood, J.A., Kenny, P.W., Major, J.S., Oldham, A.A., Rateliffe, A.H., Rivett, J.E., Roberts, D.A. and Robins, P.J., J. Med. Chem., 36 (1993) 1245.
Bradbury, R.H., Edwards, M.P., Luke, R.W.A., Pearce, R.J., Roberts, D.A., Major, J.S. and Oldham, A.A., 202nd ACS Meeting, New York, NY, U.S.A., 25–30 August, 1991, Abstr. No. 102.
Bovy, P.R., Reitz, D.B., Collins, J.T., Chamberlain, T.S., Olins, G.M., Corpus, V.M., McMahon, E.G., Palomo, M.A., Koepke, J.P., Smits, G.J., McGraw, D.E. and Gaw, J.F., J. Med. Chem., 36 (1993) 101.
Bovy, P.R., Collins, J.T., Olins, G.M., McMahon, E.G. and Hutton, W.C., J. Med. Chem. 34 (1991) 2410.
Bühlmayer, P., Ostermayer, F. and Schmidlin, T., Eur. Pat. 443 983, 1991 (Chem. Abstr. 116, 151772t, 1991).
Mohamadi, F., Richards, N.G.J., Guida, W.C., Liskamp, R., Caufield, C., Chang, G., Hendrickson, T. and Still, W.C., J. Comput. Chem., 11 (1990) 440.
Burkert, U. and Allinger, N.L., Molecular Mechanics, ACS Monograph Series, Vol. 177, American Chemical Society, Washington, DC, U.S.A., 1982.
Ponder, W.J. and Richards, F.M., J. Comput. Chem., 8 (1987) 116.
Chang, G., Guida, W.C. and Still, W.C., J. Am. Chem. Soc., 111 (1989) 4379.
Smith, G.A., Steric and Electrostatic Alignment Molecular Superposition Program, Merek Sharp & Dohme Research Laboratories, West Point, PA, U.S.A. Program obtained through Quantum Chemistry Program Exchange, QCPE 567, University of Indiana, Bloomington, IN, U.S.A.
Gasteiger, J. and Marsili, M., Tetrahedron, 36 (1980) 3219.
Marsili, M. and Gasteiger, J., Croat. Chem. Acta, 53 (1980) 601.
SYBYL, v. 6.0, Tripos Associates, St. Louis, MO, U.S.A., 1993.
Besler, B.H., Merz, K.M. and KollmanJr., P.A., J. Comput. Chem., 11 (1990) 431.
Merz, K.M. and Besler, B.H., QCPE Bull., 10 (1990) 15.
Baroni, M., Costantino, G., Cruciani, G., Riganelli, D., Valigi, R. and Clementi, S., Quant. Struct.-Act. Relatsh., 12 (1993) 9.
Joliffe, I.T., Principal Component Analysis, Springer, New York, NY, U.S.A., 1986.
Baroni, M., Clementi, S., Cruciani, G., Kettaneh-Wold, N. and Wold, S., Quant. Struct.-Act. Relatsh., 12 (1993) 225.
CramerIII, R.D., DePriest, S.A., Patterson, D.E. and Hecht, P., In Kubinyi, H. (Ed.) 3D QSAR in Drug Design: Theory, Methods and Applications, ESCOM, Leiden, The Netherlands, 1993, pp. 443–485.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Belvisi, L., Bravi, G., Catalano, G. et al. A 3D QSAR CoMFA study of non-peptide angiotensin II receptor antagonists. J Computer-Aided Mol Des 10, 567–582 (1996). https://doi.org/10.1007/BF00134180
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00134180